NCT03233737 - Pain Study to Assess Local Anesthetic Efficacy and Safety of CTY-5339 on Gingival Mucosal Tissue in Normal Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 15, 2017

Primary Completion Date

February 20, 2018

Study Completion Date

February 20, 2018

Conditions

No Disease State or Condition

Interventions

COMBINATION_PRODUCT

One spray CTY-5339-A

Metered spray bottle with ≈200 uL total spray volume. Contains the active ingredients: 14.0% Benzocaine (USP = 28 mg) and 2.0% Tetracaine Hydrochloride (USP = 4 mg). Administered in a single anesthetic spray.

DEVICE

One spray CTY-5339-CB

Metered spray bottle with ≈200 uL total spray volume. Contains the active ingredient: 14.0% Benzocaine (USP = 28 mg). Administered in a single anesthetic spray.

DEVICE

One spray CTY-5339-P

Placebo. Metered spray bottle with ≈200 uL total spray volume. Contains no active ingredient (vehicle control).

Trial Locations (1)

19104

University of Pennsylvania, School of Dental Medicine, Philadelphia